News for hackers. Stuff that matters.
Re:Qt 6.4 by not_the_fda on Thursday September 29, 2022 @03:35PM (#33025929)
The anti-tivoization clause only applies to consumer devices. There is no issues with using the LGPL in a medical device since the customer is usually commercial.
Re:Qt 6.4 by joezydeco on Thursday September 29, 2022 @05:44PM (#33027668)
If you have more documentation to back that up I'd love to see it. From my discussions with the walls of lawyers, the interpretation varies by jurisdiction.

The actual LGPLv3 text has zero instances of the word "commercial" or the word "consumer" so interpretation is all we can go by.

Re:Qt 6.4 by varajelle on Friday September 30, 2022 @03:51AM (#33032179)
Search again. The LGPLv3 is just referencing the GPL. The GPLv3 paragraph 6 define in which conditions you need to provide the installation information, and explicitly say it is only for user product:

> A “User Product” is either (1) a “consumer product”, which means any tangible personal property which is normally used for personal, family, or household purposes, or (2) anything designed or sold for incorporation into a dwelling.

Re:Qt 6.4 by not_the_fda on Friday September 30, 2022 @11:00AM (#33035807)
http://radar.oreilly.com/2007/03/gplv3-user-products-clause....

The FSF felt that consumers needed protected from tivoization but commercial users did not since they had the financial resources to fight for themselves with contract law.

Re:Qt 6.4 by LtWorf on Friday September 30, 2022 @03:49AM (#33032161)
A commercial customer has the same right as everyone else using LGPL software.
Re:Qt 6.4 by not_the_fda on Friday September 30, 2022 @10:58AM (#33035778)
They do not. http://radar.oreilly.com/2007/03/gplv3-user-products-clause....

The FSF felt that consumers needed protected from tivoization but commercial users did not since they had the financial resources to fight for themselves with contract law.